Literature DB >> 23652167

Reactive and infective dermatoses associated with adult-onset immunodeficiency due to anti-interferon-gamma autoantibody: Sweet's syndrome and beyond.

Jasper Fuk-Woo Chan1, Nigel Jeremy Trendell-Smith, Johnny Chun-Yin Chan, Ivan Fan-Ngai Hung, Bone Siu-Fai Tang, Vincent Chi-Chung Cheng, Chi-Keung Yeung, Kwok-Yung Yuen.   

Abstract

Immunodeficiency due to anti-interferon-gamma autoantibody (anti-IFN-γ autoAb) is an emerging adult-onset immunodeficiency syndrome predominantly found in Southeast Asians. It is associated with severe or disseminated infections caused by non-tuberculous mycobacteria (NTM) and other opportunistic pathogens. We describe 3 patients with anti-IFN-γ autoAb who developed reactive and infective dermatoses, and thoroughly review the existing literature on dermatoses associated with the immunodeficiency syndrome. Case 1 developed Sweet's syndrome associated with Mycobacterium chelonae lymphadenitis and penicilliosis. Case 2 suffered from multiple episodes of lobular panniculitis during recurrent infections by NTM, Penicillium marneffei and Burkholderia pseudomallei. Both cases responded to immunomodulating agents including corticosteroid and non-steroidal anti-inflammatory drugs. Case 3 had direct skin invasion by M. chelonae and responded to prolonged anti-mycobacterial therapy. A novel working algorithm is proposed for the diagnosis and treatment of these patients who may be encountered by the dermatologist and histopathologist in clinical practice.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23652167     DOI: 10.1159/000347112

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  28 in total

1.  Pathogenic autoantibodies to IFN-γ act through the impedance of receptor assembly and Fc-mediated response.

Authors:  Han-Po Shih; Jing-Ya Ding; Junel Sotolongo Bellón; Yu-Fang Lo; Pei-Han Chung; He-Ting Ting; Jhan-Jie Peng; Tsai-Yi Wu; Chia-Hao Lin; Chia-Chi Lo; You-Ning Lin; Chun-Fu Yeh; Jiun-Bo Chen; Ting-Shu Wu; Yuag-Meng Liu; Chen-Yen Kuo; Shang-Yu Wang; Kun-Hua Tu; Chau Yee Ng; Wei-Te Lei; Yu-Huan Tsai; Jou-Han Chen; Ya-Ting Chuang; Jing-Yi Huang; Félix A Rey; Hung-Kai Chen; Tse-Wen Chang; Jacob Piehler; Chih-Yu Chi; Cheng-Lung Ku
Journal:  J Exp Med       Date:  2022-07-14       Impact factor: 17.579

Review 2.  Clinical implications of interferon-γ genetic and epigenetic variants.

Authors:  Nicola L D Smith; David W Denning
Journal:  Immunology       Date:  2014-12       Impact factor: 7.397

3.  Fatal empyema thoracis caused by Schizophyllum commune with cross-reactive cryptococcal antigenemia.

Authors:  Jasper F W Chan; Jade L L Teng; Iris W S Li; Sally C Y Wong; Sally S M Leung; Po-On Ho; Kelvin K W To; Susanna K P Lau; Patrick C Y Woo; Kwok-Yung Yuen
Journal:  J Clin Microbiol       Date:  2013-11-13       Impact factor: 5.948

4.  ADA Deficiency: Evaluation of the Clinical and Laboratory Features and the Outcome.

Authors:  Deniz Cagdas; Pınar Gur Cetinkaya; Betül Karaatmaca; Saliha Esenboga; Cagman Tan; Togay Yılmaz; Ersin Gümüş; Safa Barış; Barış Kuşkonmaz; Tuba Turul Ozgur; Pawan Bali; Ines Santisteban; Diclehan Orhan; Aysel Yüce; Duygu Cetinkaya; Kaan Boztug; Michael Hershfield; Ozden Sanal; İlhan Tezcan
Journal:  J Clin Immunol       Date:  2018-05-09       Impact factor: 8.317

Review 5.  Inherited and acquired immunodeficiencies underlying tuberculosis in childhood.

Authors:  Stéphanie Boisson-Dupuis; Jacinta Bustamante; Jamila El-Baghdadi; Yildiz Camcioglu; Nima Parvaneh; Safaa El Azbaoui; Aomar Agader; Amal Hassani; Naima El Hafidi; Nidal Alaoui Mrani; Zineb Jouhadi; Fatima Ailal; Jilali Najib; Ismail Reisli; Adil Zamani; Sebnem Yosunkaya; Saniye Gulle-Girit; Alisan Yildiran; Funda Erol Cipe; Selda Hancerli Torun; Ayse Metin; Basak Yildiz Atikan; Nevin Hatipoglu; Cigdem Aydogmus; Sara Sebnem Kilic; Figen Dogu; Neslihan Karaca; Guzide Aksu; Necil Kutukculer; Melike Keser-Emiroglu; Ayper Somer; Gonul Tanir; Caner Aytekin; Parisa Adimi; Seyed Alireza Mahdaviani; Setareh Mamishi; Aziz Bousfiha; Ozden Sanal; Davood Mansouri; Jean-Laurent Casanova; Laurent Abel
Journal:  Immunol Rev       Date:  2015-03       Impact factor: 12.988

6.  Disseminated Talaromyces marneffei Infection in a Non-HIV Infant With a Homozygous Private Variant of RELB.

Authors:  Xiaofang Ding; Han Huang; Lili Zhong; Min Chen; Fang Peng; Bing Zhang; Xinyu Cui; Xiu-An Yang
Journal:  Front Cell Infect Microbiol       Date:  2021-03-15       Impact factor: 5.293

7.  Identification of specific metabolites in culture supernatant of Mycobacterium tuberculosis using metabolomics: exploration of potential biomarkers.

Authors:  Susanna K P Lau; Ching-Wan Lam; Shirly O T Curreem; Kim-Chung Lee; Candy C Y Lau; Wang-Ngai Chow; Antonio H Y Ngan; Kelvin K W To; Jasper F W Chan; Ivan F N Hung; Wing-Cheong Yam; Kwok-Yung Yuen; Patrick C Y Woo
Journal:  Emerg Microbes Infect       Date:  2015-01-28       Impact factor: 7.163

8.  Disseminated Infections with Talaromyces marneffei in Non-AIDS Patients Given Monoclonal Antibodies against CD20 and Kinase Inhibitors.

Authors:  Jasper F W Chan; Thomas S Y Chan; Harinder Gill; Frank Y F Lam; Nigel J Trendell-Smith; Siddharth Sridhar; Herman Tse; Susanna K P Lau; Ivan F N Hung; Kwok-Yung Yuen; Patrick C Y Woo
Journal:  Emerg Infect Dis       Date:  2015-07       Impact factor: 6.883

9.  Clinical findings of Talaromyces marneffei infection among patients with anti-interferon-γ immunodeficiency: a prospective cohort study.

Authors:  Zhao-Ming Chen; Zheng-Tu Li; Wei-Jie Guan; Yang-Qing Zhan; Shao-Qiang Li; Ye Qiu; Zi-Ying Lei; Hua Zhou; Sheng Lin; Xinni Wang; Zhun Li; Feng Yang; Wen Zeng; Ye Lin; Jing Liu; Jian-Quan Zhang; Feng Ye
Journal:  BMC Infect Dis       Date:  2021-06-19       Impact factor: 3.090

10.  Fatal anti-aquaporin-4 seropositive neuromyelitis optica spectrum disorder in tuberculosis.

Authors:  Siddharth Sridhar; Jasper Fuk-Woo Chan; Kwok-Yung Yuen
Journal:  BMC Infect Dis       Date:  2014-08-28       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.